Natures Sunshine Products Inc financial data

Symbol
NATR on Nasdaq
Industry
Pharmaceutical Preparations
Location
2901 West Bluegrass Blvd., Suite 100, Lehi, Utah
State of incorporation
Utah
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 226 % +1.96%
Quick Ratio 91.4 % -7.6%
Return On Equity 9.86 % +171%
Return On Assets 6.36 % +176%
Operating Margin 4.94 % +30.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 18.5M shares -3.09%
Common Stock, Shares, Outstanding 18.5M shares -3.09%
Entity Public Float 179M USD +27.3%
Common Stock, Value, Issued 114M USD -7.23%
Weighted Average Number of Shares Outstanding, Basic 18.6M shares -3.35%
Weighted Average Number of Shares Outstanding, Diluted 19.1M shares -3.18%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 442M USD +2.14%
Operating Income (Loss) 21.8M USD +32.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 21.6M USD +30.8%
Income Tax Expense (Benefit) 5.18M USD -49.9%
Net Income (Loss) Attributable to Parent 15.5M USD +190%
Earnings Per Share, Basic 0.8 USD/shares +186%
Earnings Per Share, Diluted 0.8 USD/shares +208%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 68.7M USD -0.4%
Accounts Receivable, after Allowance for Credit Loss, Current 11.3M USD -9.45%
Inventory, Net 62.3M USD -5.4%
Assets, Current 152M USD -2.48%
Deferred Income Tax Assets, Net 14.7M USD +67%
Property, Plant and Equipment, Net 44.8M USD -1.19%
Operating Lease, Right-of-Use Asset 13.7M USD -10.4%
Other Assets, Noncurrent 9.65M USD -3.58%
Assets 236M USD -0.14%
Accounts Payable, Current 8.42M USD +21.4%
Employee-related Liabilities, Current 17.1M USD +119%
Accrued Liabilities, Current 23M USD -21.1%
Contract with Customer, Liability, Current 2.22M USD +55%
Liabilities, Current 63.6M USD -10.4%
Deferred Income Tax Liabilities, Net 1.16M USD -2.84%
Operating Lease, Liability, Noncurrent 11.4M USD -9.24%
Other Liabilities, Noncurrent 1.4M USD +34.8%
Liabilities 79.4M USD -8.44%
Accumulated Other Comprehensive Income (Loss), Net of Tax -16.8M USD -3.54%
Retained Earnings (Accumulated Deficit) 53.4M USD +40.8%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 156M USD +4.69%
Liabilities and Equity 236M USD -0.14%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 2.19M USD -76.5%
Net Cash Provided by (Used in) Financing Activities 107K USD
Net Cash Provided by (Used in) Investing Activities -3.69M USD -58.7%
Common Stock, Shares Authorized 50M shares 0%
Common Stock, Shares, Issued 18.5M shares -3.09%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -4.6M USD -181%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 68.7M USD -0.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 12K USD -52%
Deferred Tax Assets, Valuation Allowance 18.5M USD +2.69%
Operating Lease, Liability 14.9M USD -17.1%
Payments to Acquire Property, Plant, and Equipment 3.69M USD +58.7%
Lessee, Operating Lease, Liability, to be Paid 16.6M USD -16.9%
Property, Plant and Equipment, Gross 140M USD +1.9%
Operating Lease, Liability, Current 3.96M USD -15.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.41M USD -25%
Lessee, Operating Lease, Liability, to be Paid, Year One 5.34M USD +8.21%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Deferred Income Tax Expense (Benefit) -157K USD +75.1%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.63M USD -15%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.84M USD -8.55%
Unrecognized Tax Benefits 900K USD +350%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.36M USD -8.96%
Depreciation, Depletion and Amortization 3.16M USD +12.7%
Deferred Tax Assets, Net of Valuation Allowance 17.3M USD +34.3%